Stock Market Reviews

QNCX (Quince Therapeutics, Inc.) News

Get the latest news, insights, and market updates on QNCX (Quince Therapeutics, Inc.). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
  SOUTH SAN FRANCISCO, Calif., May 13, 2025--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on the company’s development pipeline and reported financial results for the first quarter ended March 31, 2025.
  May 13, 2025 - $QNCX
• Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks
  Wall Street wrapped up the week with a bang, as a solid jobs report and a possible thaw in US-China trade tensions gave investors plenty to cheer about. The S&P 500 notched its longest bull run in nearly two decades, surging for a ninth consecutive day and fully erasing the losses triggered by President Trump’s early-April ‘Liberation Day’ tariff blitz. Watching the current situation from Oppenheimer, chief investment strategist John Stoltzfus believes that the markets are finally finding their
  May 4, 2025 - $QNCX
• Quince Therapeutics to Present at Citizens Life Sciences Conference
  SOUTH SAN FRANCISCO, Calif., April 30, 2025--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will present at the Citizens Life Sciences Conference taking place in New York City on Wednesday, May 7, 2025 beginning at 3:30 p.m. Eastern Time.
  Apr 30, 2025 - $QNCX
• Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
  SOUTH SAN FRANCISCO, Calif., April 03, 2025--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will present at the Jones Healthcare and Technology Innovation Conference on Wednesday, April 9, 2025.
  Apr 3, 2025 - $QNCX
• Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
  SOUTH SAN FRANCISCO, Calif., March 24, 2025--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on the company’s development pipeline and reported financial results for the fiscal year ended December 31, 2024.
  Mar 24, 2025 - $QNCX